ArticleCancer medicine2022

Impact of pre-existing interstitial lung abnormal shadow on lung injury development and severity in patients of non-small cell lung cancer treated with osimertinib.

Ryota Shibaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.